Exxact Corporation – Trademark Portfolio
Entity Type: 03
Exxact Corporation holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include EMLI, VALENCE, and TENSOREX. The owner is based in Fremont, CA.
46221 Landing Parkway
Fremont, CA 94538
Showing of trademarks Trademarks
Trademark Classifications
Exxact Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Exxact Corporation have?
Exxact Corporation has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 2 cancelled.
What trademark classes does Exxact Corporation file in?
Exxact Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Exxact Corporation's most well-known trademarks?
Exxact Corporation's registered trademark portfolio includes well-known marks such as EMLI, VALENCE, and TENSOREX. These are among 4 currently registered trademarks in the portfolio.
What is Exxact Corporation's trademark registration success rate?
Exxact Corporation has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.